Adrian Haigh - 17 Apr 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Signature
/s/ Adrian Haigh
Issuer symbol
FENC
Transactions as of
17 Apr 2024
Net transactions value
-$433,996
Form type
4
Filing time
18 Apr 2024, 21:43:32 UTC
Previous filing
26 Apr 2024
Next filing
22 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Sale $51,333 +22,222 $2.31 22,222 17 Apr 2024 Direct F1
transaction FENC Common Shares Sale $51,333 +22,222 +100% $2.31 44,444 18 Apr 2024 Direct F2
transaction FENC Common Shares Sale $220,220 -22,222 -50% $9.91 22,222 17 Apr 2024 Direct F3
transaction FENC Common Shares Sale $213,776 -22,222 -100% $9.62 0 18 Apr 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Common Shares Options Exercise $51,333 -22,222 -4.7% $2.31 449,135 17 Apr 2024 Options 22,222 $2.31 Direct F5
transaction FENC Common Shares Options Exercise $51,333 -22,222 -4.9% $2.31 426,913 18 Apr 2024 Options 22,222 $2.31 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
F2 Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
F3 Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
F4 Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
F5 Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
F6 Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.